Insider · CIK 0001341382
Topper James N
Reports to the SEC for 21 companies · SAN CARLOS, CA
Transactions
50
Companies
21
Filings
14
CIK
0001341382
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-19 | PHATPhathom Pharmaceuticals, Inc.A Award | — |
| 2025-09-15 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$15.6K |
| 2025-09-08 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$31.5K |
| 2025-08-11 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$11.3K |
| 2025-06-25 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$23K |
| 2025-06-24 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$46.5K |
| 2025-06-16 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$167K |
| 2025-06-03 | PHATPhathom Pharmaceuticals, Inc.A Award | — |
| 2025-06-03 | PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-21 | PHATPhathom Pharmaceuticals, Inc.P Purchase | +$14.6K |
| 2025-05-14 | PHATPhathom Pharmaceuticals, Inc.P Purchase | +$20.9K |
| 2025-05-13 | PHATPhathom Pharmaceuticals, Inc.P Purchase | +$3,543.344 |
| 2025-05-12 | PHATPhathom Pharmaceuticals, Inc.P Purchase | +$38.3K |
| 2025-05-09 | PHATPhathom Pharmaceuticals, Inc.P Purchase | +$107K |
| 2025-05-09 | PHATPhathom Pharmaceuticals, Inc.P Purchase | +$8,053 |
| 2025-03-26 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$25.5K |
| 2025-03-04 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$84.2K |
| 2024-05-23 | PHATPhathom Pharmaceuticals, Inc.A Award | — |
| 2024-05-23 | PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer | — |
| 2024-05-18 | ALPINE IMMUNE SCIENCES, INC.U Disposition from Tender | — |
| 2024-04-25 | ALPINE IMMUNE SCIENCES, INC.X Exercise of In-Money | +$1,200 |
| 2024-04-25 | ALPINE IMMUNE SCIENCES, INC.S Sale | −$1,226.83 |
| 2024-04-25 | ALPINE IMMUNE SCIENCES, INC.Warrant (Right to Buy)X Exercise of In-Money | — |
| 2024-03-26 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$181K |
| 2024-01-02 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2023-12-11 | ALPINE IMMUNE SCIENCES, INC.X Exercise of In-Money | +$1.85M |
| 2023-12-11 | ALPINE IMMUNE SCIENCES, INC.Warrant (Right to Buy)X Exercise of In-Money | — |
| 2023-05-25 | PHATPhathom Pharmaceuticals, Inc.A Award | — |
| 2023-05-25 | PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-01-06 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2023-01-06 | ANABANAPTYSBIO, INC · Restricted Stock UnitA Award | — |
| 2023-01-03 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2022-09-22 | PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to BuyA Award | — |
| 2022-02-10 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2022-01-03 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2021-02-10 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2021-01-04 | ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award | — |
| 2020-12-11 | Frazier Lifesciences Acquisition CorpA Award | +$5.01M |
| 2020-12-11 | Frazier Lifesciences Acquisition CorpP Purchase | +$10M |
| 2020-12-11 | Frazier Lifesciences Acquisition CorpWarrantsA Award | — |
| 2020-12-11 | Frazier Lifesciences Acquisition CorpWarrantsA Award | — |
| 2020-11-17 | Allena Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-11-16 | ANABANAPTYSBIO, INCJ Other | — |
Recent filings
- 4Topper James N0001193125-26-234572SEC(opens sec.gov)
- 4Topper James N0001341382-25-000007SEC(opens sec.gov)
- 4Topper James N0001415889-25-024111SEC(opens sec.gov)
- 4Topper James N0001415889-25-021660SEC(opens sec.gov)
- 4Topper James N0001415889-25-018316SEC(opens sec.gov)
- 4Topper James N0001415889-25-017693SEC(opens sec.gov)
- 4Topper James N0000950170-25-082454SEC(opens sec.gov)
- 4Topper James N0001415889-25-014428SEC(opens sec.gov)
- 4Topper James N0001415889-25-013134SEC(opens sec.gov)
- 4Topper James N0001415889-25-012770SEC(opens sec.gov)
- 4Topper James N0001415889-25-009198SEC(opens sec.gov)
- 4Topper James N0001415889-25-007263SEC(opens sec.gov)
- 4Topper James N0000950170-24-064842SEC(opens sec.gov)
- 4Topper James N0001626199-24-000097SEC(opens sec.gov)
Companies
- Allena Pharmaceuticals, Inc.Director, 10% Owner
- ALPINE IMMUNE SCIENCES, INC.Director
- AMICUS THERAPEUTICS, INC.Director
- ANAPTYSBIO, INCDirector, 10% OwnerANAB
- Aptinyx Inc.Director
- Arcutis Biotherapeutics, Inc.10% OwnerARQT
- Attovia Therapeutics, Inc.DirectorATTO
- COLLEGIUM PHARMACEUTICAL, INC10% OwnerCOLL
- Entasis Therapeutics Holdings Inc.10% Owner
- Frazier Lifesciences Acquisition CorpDirector, Chief Executive Officer
- GLAUKOS Corp10% OwnerGKOS
- HilleVax, Inc.10% Owner
- LA JOLLA PHARMACEUTICAL CODirector
- MBX Biosciences, Inc.10% OwnerMBX
- Mirum Pharmaceuticals, Inc.10% OwnerMIRM
- NewAmsterdam Pharma Co N.V.DirectorNAMS
- Passage BIO, Inc.10% OwnerPASG
- Phathom Pharmaceuticals, Inc.Director, 10% OwnerPHAT
- PORTOLA PHARMACEUTICALS INCDirector
- Sierra Oncology, Inc.Director, 10% Owner
- Tarsus Pharmaceuticals, Inc.10% OwnerTARS
Address
C/O ATTOVIA THERAPEUTICS, INC. 1091 INDUSTRIAL ROAD, SUITE 310
SAN CARLOS, CA, 94070